Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction

Clinical Research in Cardiology

Volumn 99, Issue 4, 2010, Pages 217-226

  Luers, Claus ^a   Wachter, Rolf ^a   Kleta, Sibylle ^a   Uhlir, Marc ^a   Koschack, Janka ^a   Scherer, Martin ^a,b   Binder, Lutz ^a   Herrmann Lingen, Christoph ^a   Zapf, Antonia ^a   Kulle, Bettina ^c   Kochen, Michael M ^a   Pieske, Burkert ^a,d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF GRAZ   (Austria)

Author keywords

Diastolic dysfunction; Heart failure; Left ventricular function; Natriuretic peptides

Indexed keywords

NATRIURETIC FACTOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; PEPTIDE ANALYSIS; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCREENING;

AGED; DIASTOLE; ECHOCARDIOGRAPHY; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HUMANS; MASS SCREENING; MIDDLE AGED; NATRIURETIC PEPTIDES; PREVALENCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77950860195     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-009-0108-z     Document Type: Article

References (35)

1. (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD investigators. N Engl J Med 327:685-691
2. (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators. N Engl J Med 325:293-302
3. RO Bonow S Bennett DE Casey Jr TG Ganiats MA Hlatky MA Konstam CT Lambrew SL Normand IL Pina MJ Radford AL Smith LW Stevenson G Burke KA Eagle HM Krumholz J Linderbaum FA Masoudi JL Ritchie JS Rumsfeld JA Spertus 2005 ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): Endorsed by the Heart Failure Society of America Circulation 112 1853 1887 10.1161/CIRCULATIONAHA.105.170072 16160201 (Pubitemid 41368160)
4. MD Cheitlin WF Armstrong GP Aurigemma GA Beller FZ Bierman JL Davis PS Douglas DP Faxon LD Gillam TR Kimball WG Kussmaul AS Pearlman JT Philbrick H Rakowski DM Thys EM Antman SC Smith Jr JS Alpert G Gregoratos JL Anderson LF Hiratzka SA Hunt V Fuster AK Jacobs RJ Gibbons RO Russell 2003 ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the1997 Guidelines for the Clinical Application of Echocardiography) J Am Soc Echocardiogr 16 1091 1110 14566308
5. AA Chen MJ Wood DG Krauser AL Baggish R Tung S Anwaruddin MH Picard JL Januzzi 2006 NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy Eur Heart J 27 839 845 10.1093/eurheartj/ehi811 1:CAS:528:DC%2BD28XjvFOntLY%3D 16510467
6. LC Costello-Boerrigter G Boerrigter MM Redfield RJ Rodeheffer LH Urban DW Mahoney SJ Jacobsen DM Heublein JC Burnett Jr 2006 Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction J Am Coll Cardiol 47 345 353 10.1016/j.jacc.2005.09.025 1:CAS:528:DC%2BD28XksFCntg%3D%3D 16412859 (Pubitemid 43063253)
7. GI Galasko SC Barnes P Collinson A Lahiri R Senior 2006 What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 27 193 200 10.1093/eurheartj/ehi559 16267076 (Pubitemid 43069036)
8. JP Goetze L Friis-Hansen JF Rehfeld B Nilsson JH Svendsen 2006 Atrial secretion of B-type natriuretic peptide Eur Heart J 27 1648 1650 10.1093/eurheartj/ehl109 1:CAS:528:DC%2BD28Xot1Cgtbw%3D 16785247 (Pubitemid 44025348)
9. KM Goode AL Clark JA Bristow KB Sykes JG Cleland 2007 Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: a cost-benefit analysis Eur J Heart Fail 9 1186 1195 10.1016/j.ejheart.2007.10.003 18006378 (Pubitemid 350138500)
10. O Gorelik D Almoznino-Sarafian M Shteinshnaider I Alon I Tzur I Sokolsky S Efrati Z Babakin D Modai N Cohen 2009 Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure Clin Res Cardiol 98 224 232 10.1007/s00392-009-0746-1 19219395
11. J Grewal R McKelvie E Lonn P Tait J Carlsson M Gianni C Jarnert H Persson 2008 BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction Eur J Heart Fail 10 252 259 10.1016/j.ejheart.2008.01.017 1:CAS:528:DC%2BD1cXjtVCit7g%3D 18331967 (Pubitemid 351343862)
12. J Grewal RS McKelvie H Persson P Tait J Carlsson K Swedberg J Ostergren E Lonn 2008 Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction Am J Cardiol 102 733 737 10.1016/j.amjcard.2008.04.048 1:CAS:528:DC%2BD1cXhtVygurzJ 18773998
13. BA Groenning I Raymond PR Hildebrandt JC Nilsson M Baumann F Pedersen 2004 Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population Heart 90 297 303 10.1136/hrt.2003.026021 1:CAS:528:DC%2BD2cXisFKqs78%3D 14966052
14. DM Hawkins SC Basak D Mills 2003 Assessing model fit by cross-validation J Chem Inf Comput Sci 43 579 586 1:CAS:528:DC%2BD3sXlsFartA%3D%3D 12653524
15. S Hettwer B Panzner-Grote R Witthaut K Werdan 2007 Isolated diastolic dysfunction-diagnostic value of tissue Doppler imaging, colour M-mode and N-terminal pro B-type natriuretic peptide Clin Res Cardiol 96 874 882 10.1007/s00392-007-0577-x 1:CAS:528:DC%2BD1cXkslCiug%3D%3D 17874035 (Pubitemid 350164932)
16. FD Hobbs RC Davis AK Roalfe R Hare MK Davies 2004 Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations Heart 90 866 870 10.1136/hrt.2003.014258 1:CAS:528:DC%2BD2cXnt1KmtL8%3D 15253955 (Pubitemid 39005929)
17. S Inoue Y Murakami K Sano H Katoh T Shimada 2000 Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation J Card Fail 6 92 96 10.1016/S1071-9164(00)90010-1 1:CAS:528:DC%2BD3cXlsFSgtL4%3D 10908082
18. B Johnston SS Seshia 1992 Discriminant analysis when all variables are ordered Stat Med 11 1023 1032 10.1002/sim.4780110804 1:STN:280: DyaK38zlvVSjtQ%3D%3D 1496190
19. J Koschack M Scherer C Luers MM Kochen D Wetzel S Kleta C Pouwels R Wachter C Herrmann-Lingen B Pieske L Binder 2008 Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care BMC Fam Pract 9 14 10.1186/1471-2296-9-14 18298821 (Pubitemid 351393227)
20. WC Lee YE Chavez T Baker BR Luce 2004 Economic burden of heart failure: a summary of recent literature Heart Lung 33 362 371 10.1016/j.hrtlng.2004.06.008 15597290 (Pubitemid 39592989)
21. KP Letsas GS Filippatos LK Pappas CC Mihas V Markou IP Alexanian M Efremidis A Sideris AS Maisel F Kardaras 2009 Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction Clin Res Cardiol 98 101 106 10.1007/s00392-008-0728-8 1:CAS:528:DC%2BD1MXhvF2msr8%3D 18975023
22. E Lubien A DeMaria P Krishnaswamy P Clopton J Koon R Kazanegra N Gardetto E Wanner AS Maisel 2002 Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings Circulation 105 595 601 10.1161/hc0502.103010 1:CAS:528:DC%2BD38XhslGgs78%3D 11827925 (Pubitemid 34123434)
23. PM Mottram R Leano TH Marwick 2003 Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function Am J Cardiol 92 1434 1438 10.1016/j.amjcard.2003.08.053 1:CAS:528:DC%2BD3sXps1Grurk%3D 14675580 (Pubitemid 37532566)
24. SF Nagueh L Rao J Soto KJ Middleton DS Khoury 2004 Haemodynamic insights into the effects of ischaemia and cycle length on tissue Doppler-derived mitral annulus diastolic velocities Clin Sci (Lond) 106 147 154 10.1042/CS20030204 (Pubitemid 38223433)
25. WJ Paulus C Tschope JE Sanderson C Rusconi FA Flachskampf FE Rademakers P Marino OA Smiseth G De Keulenaer AF Leite-Moreira A Borbely I Edes ML Handoko S Heymans N Pezzali B Pieske K Dickstein AG Fraser DL Brutsaert 2007 How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2539 2550 10.1093/eurheartj/ehm037 17428822 (Pubitemid 47614269)
26. TC Poerner B Goebel P Unglaub T Sueselbeck JM Strotmann S Pfleger M Borggrefe KK Haase 2003 Detection of a pseudonormal mitral inflow pattern: an echocardiographic and tissue Doppler study Echocardiography 20 345 356 10.1046/j.1540-8175.2003.03040.x 12848878 (Pubitemid 36606442)
27. MA Quinones CM Otto M Stoddard A Waggoner WA Zoghbi 2002 Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 15 167 184 10.1067/mje.2002.120202 11836492
28. MM Redfield 2004 Understanding "diastolic" heart failure N Engl J Med 350 1930 1931 10.1056/NEJMp048064 1:CAS:528:DC%2BD2cXjsleitbg%3D 15128890 (Pubitemid 38580193)
29. MM Redfield SJ Jacobsen JC Burnett Jr DW Mahoney KR Bailey RJ Rodeheffer 2003 Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 194 202 10.1001/jama.289.2.194 12517230 (Pubitemid 36068707)
30. MM Redfield RJ Rodeheffer SJ Jacobsen DW Mahoney KR Bailey JC Burnett Jr 2004 Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study Circulation 109 3176 3181 10.1161/01.CIR.0000130845.38133.8F 1:CAS:528:DC%2BD2cXltVCgtrw%3D 15184280
31. M Richards R Troughton J Lainchbury R Doughty S Wright 2005 Health gains by using natriuretic peptides in diagnosis, prognosis and treatment Scand J Clin Lab Invest Suppl 240 129 137 10.1080/00365510500236317 16112970 (Pubitemid 44576431)
32. A Rossi M Cicoira VG Florea G Golia ND Florea AA Khan ST Murray JT Nguyen P O'Callaghan IS Anand A Coats P Zardini C Vassanelli M Henein 2006 Chronic heart failure with preserved left ventricular ejection fraction: diagnostic and prognostic value of left atrial size Int J Cardiol 110 386 392 10.1016/j.ijcard.2005.08.049 16325283 (Pubitemid 43831223)
33. SD Solomon R Janardhanan A Verma M Bourgoun WL Daley D Purkayastha Y Lacourciere SE Hippler H Fields TZ Naqvi SL Mulvagh JM Arnold JD Thomas MR Zile GP Aurigemma 2007 Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial Lancet 369 2079 2087 10.1016/S0140-6736(07) 60980-5 1:CAS:528:DC%2BD2sXmvVKqtLo%3D 17586303 (Pubitemid 46935945)
34. R Wachter C Luers S Kleta K Griebel C Herrmann-Lingen L Binder N Janicke D Wetzel MM Kochen B Pieske 2007 Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension Eur J Heart Fail 9 469 476 10.1016/j.ejheart.2007.01.001 17303471 (Pubitemid 46561490)
35. W Youden 1950 Index for rating diagnostic tests Cancer 3 32 35 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 1:STN:280:DyaG3c%2FhsFeisw%3D%3D 15405679